These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 28542796

  • 1. Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults.
    Onwumeh J, Okwundu CI, Kredo T.
    Cochrane Database Syst Rev; 2017 May 25; 5(5):CD009818. PubMed ID: 28542796
    [Abstract] [Full Text] [Related]

  • 2. Antiretroviral resistance testing in HIV-positive people.
    Aves T, Tambe J, Siemieniuk RA, Mbuagbaw L.
    Cochrane Database Syst Rev; 2018 Nov 09; 11(11):CD006495. PubMed ID: 30411789
    [Abstract] [Full Text] [Related]

  • 3. Micronutrient supplementation in adults with HIV infection.
    Visser ME, Durao S, Sinclair D, Irlam JH, Siegfried N.
    Cochrane Database Syst Rev; 2017 May 18; 5(5):CD003650. PubMed ID: 28518221
    [Abstract] [Full Text] [Related]

  • 4. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Mbuagbaw L, Mursleen S, Irlam JH, Spaulding AB, Rutherford GW, Siegfried N.
    Cochrane Database Syst Rev; 2016 Dec 10; 12(12):CD004246. PubMed ID: 27943261
    [Abstract] [Full Text] [Related]

  • 5. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
    Eshun-Wilson I, Okwen MP, Richardson M, Bicanic T.
    Cochrane Database Syst Rev; 2018 Jul 24; 7(7):CD009012. PubMed ID: 30039850
    [Abstract] [Full Text] [Related]

  • 6. Interventions for treating tuberculous pericarditis.
    Wiysonge CS, Ntsekhe M, Thabane L, Volmink J, Majombozi D, Gumedze F, Pandie S, Mayosi BM.
    Cochrane Database Syst Rev; 2017 Sep 13; 9(9):CD000526. PubMed ID: 28902412
    [Abstract] [Full Text] [Related]

  • 7. Rapid initiation of antiretroviral therapy for people living with HIV.
    Mateo-Urdiales A, Johnson S, Smith R, Nachega JB, Eshun-Wilson I.
    Cochrane Database Syst Rev; 2019 Jun 17; 6(6):CD012962. PubMed ID: 31206168
    [Abstract] [Full Text] [Related]

  • 8. Primary antifungal prophylaxis for cryptococcal disease in HIV-positive people.
    Awotiwon AA, Johnson S, Rutherford GW, Meintjes G, Eshun-Wilson I.
    Cochrane Database Syst Rev; 2018 Aug 29; 8(8):CD004773. PubMed ID: 30156270
    [Abstract] [Full Text] [Related]

  • 9. Antihelminthics in helminth-endemic areas: effects on HIV disease progression.
    Means AR, Burns P, Sinclair D, Walson JL.
    Cochrane Database Syst Rev; 2016 Apr 14; 4(4):CD006419. PubMed ID: 27075622
    [Abstract] [Full Text] [Related]

  • 10. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS, Dokubo EK, Sint TT.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008440. PubMed ID: 20238370
    [Abstract] [Full Text] [Related]

  • 11. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW, Harris J, Humphreys E.
    Cochrane Database Syst Rev; 2010 Apr 14; (4):CD008494. PubMed ID: 20393969
    [Abstract] [Full Text] [Related]

  • 12. Treatment for HIV-associated cryptococcal meningitis.
    Tenforde MW, Shapiro AE, Rouse B, Jarvis JN, Li T, Eshun-Wilson I, Ford N.
    Cochrane Database Syst Rev; 2018 Jul 25; 7(7):CD005647. PubMed ID: 30045416
    [Abstract] [Full Text] [Related]

  • 13. School-based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents.
    Mason-Jones AJ, Sinclair D, Mathews C, Kagee A, Hillman A, Lombard C.
    Cochrane Database Syst Rev; 2016 Nov 08; 11(11):CD006417. PubMed ID: 27824221
    [Abstract] [Full Text] [Related]

  • 14. Topical microbicides for preventing sexually transmitted infections.
    Obiero J, Ogongo P, Mwethera PG, Wiysonge CS.
    Cochrane Database Syst Rev; 2021 Mar 13; 3(3):CD007961. PubMed ID: 33719075
    [Abstract] [Full Text] [Related]

  • 15. Beta-blockers for hypertension.
    Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH.
    Cochrane Database Syst Rev; 2017 Jan 20; 1(1):CD002003. PubMed ID: 28107561
    [Abstract] [Full Text] [Related]

  • 16. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N, Uthman OA, Rutherford GW.
    Cochrane Database Syst Rev; 2010 Mar 17; 2010(3):CD008272. PubMed ID: 20238364
    [Abstract] [Full Text] [Related]

  • 17. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P, Palmer SC, Ruospo M, Saglimbene VM, Rabindranath KS, Strippoli GF.
    Cochrane Database Syst Rev; 2019 Dec 02; 12(12):CD004542. PubMed ID: 31789430
    [Abstract] [Full Text] [Related]

  • 18. Interventions to improve adherence to antiretroviral therapy in children with HIV infection.
    Bain-Brickley D, Butler LM, Kennedy GE, Rutherford GW.
    Cochrane Database Syst Rev; 2011 Dec 07; 2011(12):CD009513. PubMed ID: 22161452
    [Abstract] [Full Text] [Related]

  • 19. Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old.
    Siegfried N, Davies MA, Penazzato M, Muhe LM, Egger M.
    Cochrane Database Syst Rev; 2013 Oct 10; 10(10):CD010309. PubMed ID: 24114324
    [Abstract] [Full Text] [Related]

  • 20. Artemether for severe malaria.
    Esu EB, Effa EE, Opie ON, Meremikwu MM.
    Cochrane Database Syst Rev; 2019 Jun 18; 6(6):CD010678. PubMed ID: 31210357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.